Given the multiple roles of adiponectin including metabolism control, regulation of insulin sensitivity, and stimulation of neural plasticity [50], it is possible that adiponectin may potentially be a key mediator linking the effects of combined intervention and improvement in executive function of postmenopausal women with obesity. Here, ADIPOQ is linked to obesity due to melanocortin 4 receptor deficiency.